Federal Register / Vol. 65, No. 83 / Friday, April 28, 2000 / Notices 24985

actual damages under specified

circumstances. Pursuant to Section 6(b)

of the Act, the identities of the parties

are The Budd Company, Troy, MI;

Cambridge Industries, Inc., Madison

Heights, MI; and Venture Holdings

Corporation, doing business as Bailey

Manufacturing Corporation, Fraser, MI.

The nature and objectives of the venture

are to engage in joint research projects

to address, analyze and resolve

manufacturing problems common to

molders of plastic sheet molding

compounds including, for example,

coatings; edge finishing; repair systems;

surface measurement; and shipping rack

design.

Constance K. Robinson,

Director of Operations Antitrust Division.

[FR Doc. 00–10597 Filed 4–27–00; 8:45 am]

BILLING CODE 4410–11–M

DEPARTMENT OF JUSTICE

Antitrust Division

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993—The Frame Relay Forum

Notice is hereby given that, on

December 8, 1999, pursuant to Section

6(a) of the National Cooperative

Research and Production Act of 1993,

15 U.S.C. 4301 et seq. (‘‘the Act’’), The

Frame Relay Forum (FRF) has filed

written notifications simultaneously

with the Attorney General and the

Federal Trade Commission disclosing

changes in its membership status. The

notifications were filed for the purpose

of extending the Act’s provisions

limiting the recovery of antitrust

plaintiffs to actual damages under

specified circumstances. Specifically,

ASC, Vienna, VA; TeraGen, San Jose,

CA; Science Dynamics, Cherry Hill, NJ;

Advantel S.A., Garza Garcia, Nuevo

Leon, MEXICO; and T–DATA, Bonn,

GERMANY have joined FRF as

worldwide members. Ascend

Communication, Westford, MA has

changed its name to Lucent

Technologies, Westford, MA; and

Hewlett Packard, Colorado Springs, CO

has changed its name to Agilent

Technologies, Colorado Springs, CO.

No other changes have been made in

either the membership or planned

activity of the group research project.

Membership in this group research

project remains open, and The Frame

Relay Forum (FRF) intends to file

additional written notification

disclosing all changes in membership.

On April 10, 1992, The Frame Relay

Forum (FRF) filed its original

notification pursuant to Section 6(a) of

the Act. The Department of Justice

published a notice in the Federal

Register pursuant to Section 6(b) of the

Act on July 2, 1992 (57 FR 29537).

The last notification was filed with

the Department on July 22, 1999. A

notice was published in the Federal

Register pursuant to Section 6(b) of the

Act on December 2, 1999 (64 FR 67589).

Constance K. Robinson,

Director of Operations Antitrust Division.

[FR Doc. 00–10600 Filed 4–27–00; 8:45 am]

BILLING CODE 4410–11–M

DEPARTMENT OF JUSTICE

Antitrust Division

Notice Pursuant to the National

Cooperative Research and Production

Act of 1993; Wireless Application

Protocol Forum (‘‘WAP’’)

Notice is hereby given that, on July 9,

1999, pursuant to section 6(a) of the

National Cooperative Research and

Production Act of 1993, 15 U.S.C. 4301

et seq. (‘‘the Act’’), Wireless Application

Protocol Forum (‘‘WAP’’) has filed

written notifications simultaneously

with the Attorney General and the

Federal Trade Commission disclosing

changes in its membership status. The

notifications were filed for the purpose

of extending the Act’s provisions

limiting the recovery of antitrust

plaintiffs to actual damages under

specified circumstances. Specifically,

ASL, Bristol, United Kingdom; AUSystem Mobile AB, Stockholm,

SWEDEN; Baltimore Technologies,

Dublin, Ireland; BEA WebXpress;, San

Francisco, CA; Cap Gemini, Puteaux,

Cedex, France; Digital Mobility Ltd.,

London, United Kingdom; East Digifone,

Dublin, Ireland; Hitachi Ltd., Tokyo,

Japan; Japan Telecom Ltd., Tokyo,

Japan; Lexacom Inc., Montreal, Quebec,

Canada; MapQuest.com Inc.,

Mountville, PA; Merita Bank Plc,

Merita, Finland; Microsoft, Redmond,

WA; Mobile Services Group, Irving, TX;

Orange Communications SA, Lausanne,

Switzerland; Peramon Technology Ltd.,

Reading, United Kingdom; Razorfish,

Inc., Helsinki, Finland; Sun

Microsystems, Palo Alto, CA; TAN TAU

Software Inc., Utrecht, The Netherlands;

Telecom Wireless Solutions, Alpharetta,

GA; UBS, Zurich, Switzerland; Usha

Communication Technology, Portland,

OR; WapIT Ltd., Helsinki, Finland; and

Wireless Knowledge, San Diego, CA

have been added as parties to this

venture.

No other changes have been made in

either the membership or planned

activity of the group research project.

Membership in this group research

project remains open, and Wireless

Application Protocol Forum (‘‘WAP’’)

intends to file additional written

notification disclosing all changes in

membership.

On March 18, 1998, Wireless

Application Protocol Forum (‘‘WAP’’)

filed its original notification pursuant to

section 6(a) of the Act. The Department

of Justice published a notice in the

Federal Register pursuant to section

6(b) of the Act on December 31, 1998

(63 FR 72333).

The last notification was filed with

the Department on April 6, 1999. A

notice has not yet been published in the

Federal Register.

Constance K. Robinson,

Director of Operations Antitrust Division.

[FR Doc. 00–10603 Filed 4–27–00; 8:45 am]

BILLING CODE 4410–11–M

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

Manufacturer of Controlled

Substances Notice of Application

Pursuant to § 1301.33(a) of Title 21 of

the Code of Federal Regulations (CFR),

this is notice that on January 24, 2000,

Eli-Elsohly Laboratories, Inc., 5

Industrial Park Drive, Oxford,

Mississippi 38655, made application by

renewal to the Drug Enforcement

Administration (DEA) for registration as

a bulk manufacturer of the basic classes

of controlled substances listed below:

Drug Schedule

Tetrahydrocannabinols (7370) ..... I

Dihydromorphine (9145) ............... I

Amphetamine (1100) .................... II

Methamphetamine (1105) ............ II

Cocaine (9041) ............................. II

Codeine (9050) ............................. II

Dihydrocodeine (9120) ................. II

Oxycodone (9143) ........................ II

Hydromorphone (9150) ................ II

Benzoylecqonine(9180) ................ II

Hydrocodone (9193) ..................... II

Morphine (9300) ........................... II

The firm plans to bulk manufacture

non-deuterated controlled substances

for use as analytical standards and

deuterated controlled substances for

ause as internal standards.

Any other such applicant and any

person who is persently registered with

DEA to manufacturer such substance

may file comments or objections to the

issance of the proposed registration.

Any such comments or objections

may be addressed, in quintuplicate, to